医学
临床试验
疾病
放射性武器
重症监护医学
病理
外科
作者
Peter Bede,Pierre Pradat,Javier de Lope,Patrick Vourc’h,Hélène Blasco,Philippe Corcia
标识
DOI:10.1016/j.neurol.2021.04.008
摘要
Primary Lateral Sclerosis (PLS) is an uncommon motor neuron disorder. Despite the well-recognisable constellation of clinical manifestations, the initial diagnosis can be challenging and therapeutic options are currently limited. There have been no recent clinical trials of disease-modifying therapies dedicated to this patient cohort and awareness of recent research developments is limited. The recent consensus diagnostic criteria introduced the category 'probable' PLS which is likely to curtail the diagnostic journey of patients. Extra-motor clinical manifestations are increasingly recognised, challenging the view of PLS as a 'pure' upper motor neuron condition. The post mortem literature of PLS has been expanded by seminal TDP-43 reports and recent PLS studies increasingly avail of meticulous genetic profiling. Research in PLS has gained unprecedented momentum in recent years generating novel academic insights, which may have important clinical ramifications.
科研通智能强力驱动
Strongly Powered by AbleSci AI